Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980
- 1 October 2013
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 24 (10), 2657-2671
- https://doi.org/10.1093/annonc/mdt301
Abstract
After a peak in the late 1980s, cancer mortality in Europe has declined by ~10% in both sexes up to the early 2000s. We provide an up-to-date picture of patterns and trends in mortality from major cancers in Europe. We analyzed cancer mortality data from the World Health Organization for 25 cancer sites and 34 European countries (plus the European Union, EU) in 2005-2009. We computed age-standardized rates (per 100,000 person-years) using the world standard population and provided an overview of trends since 1980 for major European countries, using joinpoint regression. Cancer mortality in the EU steadily declined since the late 1980s, with reductions by 1.6% per year in 2002-2009 in men and 1% per year in 1993-2009 in women. In western Europe, rates steadily declined over the last two decades for stomach and colorectal cancer, Hodgkin lymphoma, and leukemias in both sexes, breast and (cervix) uterine cancer in women, and testicular cancer in men. In central/eastern Europe, mortality from major cancer sites has been increasing up to the late 1990s/early 2000s. In most Europe, rates have been increasing for lung cancer in women and for pancreatic cancer and soft tissue sarcomas in both sexes, while they have started to decline over recent years for multiple myeloma. In 2005-2009, there was still an over twofold difference between the highest male cancer mortality in Hungary (235.2/100,000) and the lowest one in Sweden (112.9/100,000), and a 1.7-fold one in women (from 124.4 in Denmark to 71.0/100,000 in Spain). With the major exceptions of female lung cancer and pancreatic cancer in both sexes, in the last quinquennium, cancer mortality has moderately but steadily declined across Europe. However, substantial differences across countries persist, requiring targeted interventions on risk factor control, early diagnosis, and improved management and pharmacological treatment for selected cancer sites.Keywords
Funding Information
- Italian Association for Cancer Research (AIRC Grant No. 10264)
- Swiss Leagues against Cancer, and the Swiss Foundation for Research against Cancer (KFS Grant No. 2437-08-2009)
This publication has 41 references indexed in Scilit:
- The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UKThe Lancet, 2013
- Lung cancer mortality in European women: Trends and predictionsLung Cancer, 2012
- Trends in mortality from leukemia in Europe: An update to 2009 and a projection to 2012International Journal of Cancer, 2012
- The decline in breast cancer mortality in Europe: An update (to 2009)The Breast, 2012
- Pancreatic cancer: Overview of descriptive epidemiologyMolecular Carcinogenesis, 2011
- Trends in Mortality From Urologic Cancers in Europe, 1970–2008European Urology, 2011
- National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participantsThe Lancet, 2011
- Recent trends in colorectal cancer mortality in EuropeInternational Journal of Cancer, 2010
- Mortality Results from a Randomized Prostate-Cancer Screening TrialThe New England Journal of Medicine, 2009
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal of Cancer, 2008